查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1500689

人乳寡糖市场 - 全球规模、份额、趋势分析、机会、预测报告，2019-2030

Human Milk Oligosaccharides Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2030, Segmented By Product Type, By End Use Application, By Form, By Region
出版日期: | 出版商: Blueweave Consulting | 英文 235 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024年至2030年，全球人乳寡糖市场规模将以21.13%的复合年增长率大幅成长，2030年将达到2,5012万美元。

全球人乳寡糖市场的蓬勃发展得益于两个关键成分的共同作用：人乳寡糖(HMO) 和生长因子。 HMO 是婴儿无法消化的复杂碳水化合物，可充当益生元，餵养肠道中的有益细菌并培养健康的微生物组。这种健康的肠道环境对宝宝免疫系统的发育有着重要作用。另一方面，生长因子是直接向身体细胞发出生长、成熟和发育讯号的蛋白质分子。

领先的策略咨询和市场研究公司BlueWeave Consulting在最近的研究中估计，2023年全球人乳寡糖市场规模为1.0085亿美元。 BlueWeave预测，在2024-2030年预测期内，全球人乳寡糖市场规模将以21.13%的复合年增长率扩大，到2030年将达到2.5012亿美元。由于人们越来越认识到 HMO 对婴儿的健康益处（包括促进免疫系统和肠道发育），全球人乳寡糖市场正在经历显着增长。这与父母为孩子寻求更天然和功能性食品的更广泛趋势是一致的。此外，添加 HMO 的婴儿奶粉的日益普及正在推动需求，特别是在母乳哺​​育率较低的地区。最后，关于 HMO 对成人在消化器官系统健康和疾病预防等领域的潜在益处的研究正在创造新的市场机会，并进一步推动全球 HMO 市场的发展。

机会：机能性食品与健康领域快速成长的机会

人乳寡糖(HMO) 市场在各个领域提供了丰富而令人兴奋的机会，这得益于对其健康益处的科学认识的不断加深以及全球对创新机能性食品。婴儿营养市场是 HMO 的主要动力，越来越多的父母寻求模仿母乳成分的婴儿奶粉奶粉。 HMO 在支持婴儿肠道发育和免疫力方面发挥着重要作用，完全符合天然和功能性成分的趋势。随着研究不断揭示各种 HMO 的特异性功能，预计将有更多有针对性的奶粉能够满足特定婴儿的需求。这种有针对性的方法相信将进一步推动婴儿营养领域的 HMO 市场。 HMO 的应用远远超出了婴儿奶粉。食品和饮料製造商正在认识到 HMO 在增强各种产品的营养成分方面的潜力。成人能量饮料、优格和谷类食品中的 HMO 强化可以满足消费者对支持肠道健康和免疫力的机能性食品日益增长的兴趣。此外，HMO 在运动营养产品中的潜在应用以帮助恢復和提高表现是另一个有前途的途径。目前，HMO 的大规模生产依赖于复杂的酶促或化学合成过程。然而，使用微生物培养物或工程酵母菌株的发酵技术的进步对于经济高效永续的HMO 生产具有巨大潜力。这不仅确保了稳定的供应以满足不断增长的需求，而且还可能降低富含 HMO 的产品的成本，使消费者更容易获得这些产品。

地缘政治紧张局势对全球人乳寡糖市场的影响

全球人乳寡糖（HMO）市场虽然充满机会，但由于地缘政治紧张局势而面临重大挑战。这些紧张局势可能会扰乱供应链，影响原料供应，影响消费者信心，并可能阻碍市场的成长轨迹。复杂的国际贸易网络很容易陷入地缘政治衝突。在压力时期实施的关税、制裁和出口限制可能会严重扰乱原材料和 HMO 成品的流动。例如，HMO 合成所必需的关键酶的主要生产商可能位于政治不稳定的国家。这可能会导致缺货和价格波动，影响製造商并最终影响消费者。此外，紧张的国际关係造成的物流瓶颈可能会进一步阻碍货物的顺利流动，造成延误并可能导致产品损坏。 HMO 的生产取决于特定的原料，例如牛奶中的乳糖、酵素或微生物合成的前体。地缘政治紧张局势可能会扰乱这些原材料的采购，特别是如果它们来自经历衝突或政治不稳定的地区。这可能导致供不应求和价格上涨，挤压製造商的利润并限制向消费者提供富含 HMO 的产品。地缘政治不稳定会带来不确定性，并可能削弱消费者信心。这可能特别会影响机能性食品市场，例如富含 HMO 的产品，在经济不确定的情况下，消费者可能会犹豫是否要花钱购买高级产品。此外，地缘政治紧张局势导致的外汇波动可能会影响 HMO 生产和最终产品的整体成本，导致价格上涨，进一步抑制消费者需求。

全球人乳寡糖市场

全球人乳寡糖市场 - 副产品

根据产品类型，2'-岩藻糖基乳糖领域以 2'-FL 为主，它是母乳中天然存在的最丰富、研究最充分的 HMO 之一，在婴儿营养和机能性食品应用中非常受欢迎。由于其结构与人类母乳中的寡糖相似，因此具有强大的生物学相关性和潜在的健康益处。其次，研究和开发表明，2'-FL 可以支持健康的肠道菌群，促进免疫系统发育，并降低婴儿感染疾病和过敏的风险，并强调它对健康有正面影响。这些已证实的健康益处导致对含有 2'-FL 的产品的需求增加，例如婴儿奶粉、婴儿食品和营养食品。此外，生物技术製程的进步使得商业规模生产 2'-FL 成为可能，从而更容易配製到各种消费品中。这种可用性，加上消费者对 HMO 及其益处的认识不断提高，正在推动 HMO 市场中 2'-FL 细分市场的成长。此外，监管部门的核准和医疗保健专业人员的支持进一步促进了 2'-FL 的崛起，巩固了其作为全球 HMO 市场关键成长领域的地位。

全球人乳寡糖市场－依最终用途

由于母乳中天然丰富的人乳寡糖（HMO），婴儿营养品产业预计在预测期内将显着成长。 HMO 透过培养健康的肠道菌丛、增强免疫系统发育以及促进营养物质的消化和吸收，在婴儿健康中发挥着至关重要的作用。由于母乳被认为是婴儿营养的黄金标准，製造商努力在婴儿奶粉中尽可能模仿母乳的成分，从而添加了 HMO。此外，HMO 被认为可以提供基本营养以外的益处，例如降低婴儿感染疾病、过敏和发炎疾病的风险。这种付加的健康价值促使父母和医疗保健专业人员更喜欢添加 HMO 的婴儿奶粉，从而增加了市场需求。

此外，研究和临床研究不断证明 HMO 对婴儿健康结果有正面影响，进一步增强了对婴儿奶粉的需求。卫生当局的监管核准和认可也促进了 HMO 浓缩婴儿奶粉越来越被接受和采用，巩固了其作为婴儿营养中广受欢迎的成分的地位。

全球人乳寡糖市场—依形式

根据形态，无定形粉末由于其优异的溶解度和生物利用度预计将在预测期内增长。由于其非结晶结构，非晶质粉末很容易溶解在液体中，例如婴儿奶粉、饮料和营养食品。这项特性提高了其可用性，并使其能够更好地融入各种食品和营养产品中，而不会牺牲质地或味道。

此外，与结晶质粉末相比，结晶质粉末通常具有更高的稳定性和保质期，使其成为寻求长期产品稳定性和品质的製造商的首选。非晶质粉末的溶解度和稳定性增强，使其在市场上广受欢迎，特别是在快速溶解、有效输送和产品寿命是影响消费者满意度和产品性能的关键因素的应用中。

全球人乳寡糖市场－按地区划分

关于人乳寡糖全球市场的详细研究报告涵盖了全球主要地区：北美、欧洲、亚太地区、拉丁美洲、中东和非洲。该地区专注于婴幼儿营养和医疗保健，家长和医疗保健专业人员对幼儿营养的重要性有很高的认识。这种认知正在推动婴儿奶粉和婴儿食品中对 HMO 的需求，因为它们模仿了母乳的好处。此外，北美在食品和营养行业拥有先进的研发能力，导致基于 HMO 的产品不断创新和产品进步。这项创新包括新配方、改进的生产技术和增强的产品功效，以吸引消费者并推动市场成长。此外，北美有利的法律规范和标准支持 HMO 的商业化和行销，为市场扩张创造了有利的环境。主要市场参与者、强大的分销网络和战略合作伙伴关係的存在进一步促进了北美在全球 HMO 市场的主导地位，并对整体市场的成长和开拓做出了重大贡献。

竞争格局

全球人乳寡糖市场分散，众多参与者进入市场。全球人乳寡糖市场的主要公司包括BASF SE、Abbott Laboratories、Chr. Hansen Holding A/S、International Flavors & Fragrances Inc.（杜邦）、Koninklijke DSM NV、Merck &Co.Inc、Royal FrieslandCampina NV Inc.、ZuChem。 .、Inbiose NV、Glycosyn LLC、Kirin Holdings Company (Kyowa Hakko Bio)、Jennewein Biotechnologie GmbH、雀巢SA、InnoBio Ltd.、Elicityl SA。为了进一步增加市场占有率，这些公司正在采取各种策略，例如併购、合作、合资、授权合约和新产品发布。公司采取的主要行销策略是设施扩张、产品多元化、联盟、合资、合作和收购，以扩大客户范围并在整个市场中获得竞争优势。

该报告的详细分析提供了有关全球人乳寡糖市场的成长潜力、未来趋势和统计数据的资讯。它还涵盖了推动市场总规模预测的因素。该报告致力于提供全球人乳寡糖市场的最新技术趋势以及产业见解，以帮助决策者做出明智的策略决策。此外，也分析了市场成长动力、挑战和竞争动态。

目录

第一章 研究框架

第 2 章执行摘要

第三章全球人乳寡糖市场洞察

  • 产业价值链分析
  • DROC分析
    • 生长促进因子
      • 提高对 HMO 益处的认识
      • 机能性食品日益受到关注
      • 优质婴儿奶粉的需求增加
    • 抑制因素
      • 与传统婴儿奶粉的竞争
      • 消费者认知度与接受度
      • 生产成本高
    • 机会
      • 拓展新用途
      • HMO 生产的技术进步
      • 亚太地区和拉丁美洲不断成长的市场
    • 任务
      • 监管障碍
      • 有限的科学研究
  • 科技进步/最新趋势
  • 法律规范
  • 波特五力分析

第四章全球人乳寡糖市场：行销策略

第五章全球人乳寡糖市场概况

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 产品类别
      • 2'-岩藻糖基乳糖
      • 乳-N-新四糖 (LNnT)
      • 3-岩藻糖基乳糖
      • 3'-SL（3'-唾液酸乳糖）
      • 6'-SL（6'-唾液酸乳糖）
      • 其他的
    • 按最终用途
      • 婴奶粉
      • 饮食补充剂
      • 机能性食品和饮料
    • 按形式
      • 无定形粉末
      • 结晶粉
    • 按地区
      • 北美洲
      • 欧洲
      • 亚太地区 (APAC)
      • 拉丁美洲 (LATAM)
      • 中东和非洲 (MEA)

第六章 北美人乳寡糖市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 产品类别
    • 按最终用途
    • 按形式
    • 按国家/地区
      • 美国
      • 加拿大

第七章欧洲人乳寡糖市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 产品类别
    • 按最终用途
    • 按形式
    • 按国家/地区
      • 德国
      • 英国
      • 义大利
      • 法国
      • 西班牙
      • 比利时
      • 俄罗斯
      • 荷兰
      • 其他欧洲国家

第八章亚太人乳寡糖市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 产品类别
    • 按最终用途
    • 按形式
    • 按国家/地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 澳洲/纽西兰
      • 印尼
      • 马来西亚
      • 新加坡
      • 越南
      • 亚太地区其他国家

第九章 拉丁美洲人乳寡糖市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 产品类别
    • 按最终用途
    • 按形式
    • 按国家/地区
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘鲁
      • 其他拉丁美洲

第十章中东及非洲人乳寡糖市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 产品类别
    • 按最终用途
    • 按形式
    • 按国家/地区
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 卡达
      • 科威特
      • 南非
      • 奈及利亚
      • 阿尔及利亚
      • 其他中东/非洲

第十一章竞争格局

  • 主要企业及其产品列表
  • 2023年全球人乳寡糖市场占有率分析
  • 竞争基准化分析：透过管理参数
  • 重大策略发展（合併、收购、联盟等）

第十二章地缘政治紧张局势加剧对全球人乳寡糖市场的影响

第十三章 公司简介（公司简介、财务矩阵、竞争格局、关键人员、主要竞争对手、联络方式、策略展望、SWOT分析）

  • BASF SE
  • Abbott Laboratories
  • Chr. Hansen Holding A/S
  • International Flavors &Fragrances Inc.（DuPont）
  • Koninklijke DSM NV
  • Merck &Co. Inc.
  • Royal FrieslandCampina NV
  • ZuChem Inc.
  • Inbiose NV
  • Glycosyn LLC
  • Kirin Holdings Company（Kyowa Hakko Bio）
  • Jennewein Biotechnologie GmbH
  • Nestle SA
  • InnoBio Ltd.
  • Elicityl SA
  • 其他主要企业

第十四章 主要策略建议

第十五章调查方法

简介目录
Product Code: BWC23330

Global Human Milk Oligosaccharide Market Size Set Expands at Significant CAGR of 21.13% During 2024-2030 to Reach USD 250.12 Million by 2030

Global Human Milk Oligosaccharide Market is flourishing as the two key components working in tandem are human milk oligosaccharides (HMOs) and growth factors. HMOs, complex sugars indigestible by the infant, act as prebiotics, feeding the good bacteria in the gut and fostering a healthy microbiome. This healthy gut environment plays a crucial role in the baby's immune system development. Growth factors, on the other hand, are protein molecules that directly signal the body's cells to grow, mature, and develop.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Human Milk Oligosaccharide Market size at USD 100.85 Million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Human Milk Oligosaccharide Market size to expand at a CAGR of 21.13% reaching a value of USD 250.12 Million by 2030. The Global Human Milk Oligosaccharide Market is experiencing significant growth, propelled by rising awareness of the health benefits of HMOs for infants, including boosting their immune system and gut development. This aligns with a broader trend of parents seeking out more natural and functional foods for their children. Additionally, the growing popularity of infant formula with added HMOs is driving demand, particularly in regions with lower breastfeeding rates. Lastly, research into the potential benefits of HMOs for adults in areas like digestive health and disease prevention is creating new market opportunities, further propelling the global HMO market forward.

Opportunity: Burgeoning Opportunity in the Functional Food and Health Space

The human milk oligosaccharide (HMO) market presents a wealth of exciting opportunities across various segments, driven by increasing scientific understanding of their health benefits and a growing global demand for innovative functional foods. The infant nutrition market is a primary driver for HMOs, with parents increasingly seeking out infant formulas that mimic the composition of breast milk. HMOs play a crucial role in supporting infant gut development and immunity, aligning perfectly with this trend towards natural and functional ingredients. As research continues to unveil the specific functionalities of various HMOs, we can expect even more targeted formulas catering to specific infant needs. This targeted approach will further propel the HMO market within the infant nutrition sector. The application of HMOs extends far beyond infant formula. Food and beverage manufacturers are recognizing the potential of HMOs to enhance the nutritional profile of various products. HMO fortification in adult nutritional drinks, yogurts, and cereals can cater to growing consumer interest in functional foods that support gut health and immunity. Additionally, the potential application of HMOs in sports nutrition products to aid recovery and enhance performance is another promising avenue. Currently, large-scale production of HMOs relies on complex enzymatic or chemical synthesis processes. However, advancements in fermentation technology using microbial cultures or engineered yeast strains hold immense promise for cost-effective and sustainable HMO production. This will not only ensure a steady supply to meet growing demand but also potentially bring down the cost of HMO-fortified products, making them more accessible to consumers.

Impact of Geopolitical Tensions on Global Human Milk Oligosaccharide Market

The global human milk oligosaccharide (HMO) market, while brimming with opportunities, faces a significant challenge in the form of geopolitical tensions. These tensions can disrupt supply chains, influence raw material availability, and impact consumer confidence, potentially hindering the market's growth trajectory. The intricate web of international trade can be easily entangled by geopolitical conflicts. Tariffs, sanctions, and export restrictions implemented during times of tension can significantly disrupt the flow of raw materials and finished HMO products. For instance, a major producer of a key enzyme crucial for HMO synthesis might be located in a country experiencing political unrest. This can lead to shortages and price fluctuations, impacting manufacturers and ultimately consumers. Additionally, logistical bottlenecks arising from strained international relations can further impede the smooth movement of goods, creating delays and potentially causing product spoilage. HMO production relies on specific raw materials, such as lactose from milk and precursors for enzymatic or microbial synthesis. Geopolitical tensions can disrupt the sourcing of these raw materials, especially if they originate from regions experiencing conflict or political instability. This can lead to shortages and price hikes, squeezing profit margins for manufacturers and potentially limiting the availability of HMO-fortified products for consumers. Geopolitical instability can breed uncertainty and erode consumer confidence. This can particularly impact the market for functional foods like HMO-fortified products, where consumers might be hesitant to spend on premium offerings during uncertain economic times. Additionally, currency fluctuations arising from geopolitical tensions can affect the overall cost of HMO production and finished goods, potentially leading to price hikes that further dampen consumer demand.

Global Human Milk Oligosaccharide Market

Global Human Milk Oligosaccharides Market - By Product

Based on product type, 2'-Fucosyllactose segment is expected to grow in the forecast period as 2'-FL is one of the most abundant and well-studied HMOs naturally present in breast milk, making it highly desirable for infant nutrition and functional food applications. Its structural similarity to the oligosaccharides found in human milk gives it a strong biological relevance and potential health benefits. Secondly, research has highlighted the positive effects of 2'-FL on infant health, including its role in supporting a healthy gut microbiome, enhancing immune system development, and potentially reducing the risk of infections and allergies in infants. These documented health benefits have increased the demand for products containing 2'-FL, such as infant formulas, baby foods, and dietary supplements. Moreover, advancements in biotechnological processes have enabled the production of 2'-FL on a commercial scale, making it more accessible for incorporation into various consumer products. This availability, coupled with growing consumer awareness of HMOs and their benefits, has fueled the growth of the 2'-FL segment in the HMOs market. Additionally, regulatory approvals and endorsements from healthcare professionals further contribute to the prominence of 2'-FL, solidifying its position as a leading growth segment within the global HMOs market.

Global Human Milk Oligosaccharides Market - By End Use Application

The infant nutrition segment is anticipated to experience significant growth in the forecast period due to the natural abundance of Human Milk Oligosaccharides (HMOs) in human breast milk. HMOs play pivotal roles in infant health by fostering a healthy gut microbiome, bolstering immune system development, and facilitating the digestion and absorption of nutrients. As breast milk is considered the gold standard for infant nutrition, manufacturers strive to mimic its composition as closely as possible in infant formula, leading to the inclusion of HMOs. Furthermore, HMOs are believed to offer benefits that extend beyond basic nutrition, such as reducing the risk of infections, allergies, and inflammatory conditions in infants. This added health value drives parents and healthcare professionals to prefer infant formulas supplemented with HMOs, enhancing the market demand.

Furthermore, research and clinical studies continue to demonstrate the positive impact of HMOs on infant health outcomes, further bolstering their demand in infant formula. Regulatory approvals and endorsements from health authorities also contribute to the growing acceptance and adoption of HMO-enriched infant formulas, solidifying their position as a sought-after component in early childhood nutrition.

Global Human Milk Oligosaccharides Market - By Form

Based on Form, the amorphous Powder is expected to grow in the forecast period owing to its superior solubility and bioavailability. Amorphous Powder has a non-crystalline structure, which makes it easier to dissolve in liquids, such as infant formula, beverages, or dietary supplements. This property enhances its usability and allows for better incorporation into various food and nutritional products without compromising on texture or taste.

Additionally, Amorphous Powder typically exhibits improved stability and shelf-life compared to Crystalline Powder, making it a preferred choice for manufacturers seeking long-term product stability and quality. The enhanced solubility and stability of Amorphous Powder contribute to its higher demand in the market, especially in applications where quick dissolution, effective delivery, and product longevity are essential factors influencing consumer satisfaction and product performance.

Global Human Milk Oligosaccharides Market - By Region

The in-depth research report on the Global Human Milk Oligosaccharides Market covers several major regions across the globe: North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The region has a strong emphasis on infant nutrition and healthcare, with a high awareness among parents and healthcare professionals regarding the importance of early childhood nutrition. This awareness drives the demand for HMOs in infant formula and baby foods, as they mimic the benefits of breast milk. Additionally, North America boasts advanced research and development capabilities in the food and nutrition industry, leading to continuous innovation and product advancements in HMO-based products. This innovation includes novel formulations, improved production techniques, and enhanced product efficacy, attracting consumers and boosting market growth. Additionally, favorable regulatory frameworks and standards in North America support the commercialization and marketing of HMOs, fostering a conducive environment for market expansion. The presence of key market players, strong distribution networks, and strategic partnerships further contribute to North America's dominant position in the global HMOs market, making it a significant contributor to overall market growth and development.

Competitive Landscape

The Global Human Milk Oligosaccharide Market is fragmented, with numerous players serving the market. Major players operating in the Global Human Milk Oligosaccharides Market include BASF SE, Abbott Laboratories, Chr. Hansen Holding A/S, International Flavors & Fragrances Inc. (DuPont), Koninklijke DSM N.V., Merck & Co. Inc., Royal FrieslandCampina N.V., ZuChem Inc., Inbiose NV, Glycosyn LLC, Kirin Holdings Company (Kyowa Hakko Bio), Jennewein Biotechnologie GmbH, Nestle S.A., InnoBio Ltd., Elicityl SA. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches. The key marketing strategies adopted by the players are facility expansion, product diversification, alliances, collaborations, partnerships, and acquisitions to expand their customer reach and gain a competitive edge in the overall market.

The report's in-depth analysis provides information about growth potential, upcoming trends, and the Global Human Milk Oligosaccharide Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Human Milk Oligosaccharide Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the market's growth drivers, challenges, and competitive dynamics.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Human Milk Oligosaccharide Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Rising awareness of the benefits of HMOs
      • 3.2.1.2. Increasing focus on functional foods
      • 3.2.1.3. Growing demand for premium infant formula
    • 3.2.2. Restraints
      • 3.2.2.1. Competition from conventional infant formula
      • 3.2.2.2. Consumer perception and acceptance
      • 3.2.2.3. High cost of production
    • 3.2.3. Opportunities
      • 3.2.3.1. Expansion into new applications
      • 3.2.3.2. Technological advancements in HMO production
      • 3.2.3.3. Growing markets in Asia Pacific and Latin America
    • 3.2.4. Challenges
      • 3.2.4.1. Regulatory hurdles
      • 3.2.4.2. Limited scientific research
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Human Milk Oligosaccharide Market: Marketing Strategies

5. Global Human Milk Oligosaccharide Market Overview

  • 5.1. Market Size & Forecast, 2019-2030
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share and Forecast
    • 5.2.1. By Product Type
      • 5.2.1.1. 2'-Fucosyllactose
      • 5.2.1.2. Lacto-N-neotetraose (LNnT)
      • 5.2.1.3. 3-Fucosyllactose
      • 5.2.1.4. 3'-SL (3'-sialyllactose)
      • 5.2.1.5. 6'-SL (6'-sialyllactose)
      • 5.2.1.6. Others
    • 5.2.2. By End Use Application
      • 5.2.2.1. Infant Formula
      • 5.2.2.2. Dietary Supplement
      • 5.2.2.3. Functional Food & Beverages
    • 5.2.3. By Form
      • 5.2.3.1. Amorphous Powder
      • 5.2.3.2. Crystalline Powder
    • 5.2.4. By Region
      • 5.2.4.1. North America
      • 5.2.4.2. Europe
      • 5.2.4.3. Asia Pacific (APAC)
      • 5.2.4.4. Latin America (LATAM)
      • 5.2.4.5. Middle East and Africa (MEA)

6. North America Human Milk Oligosaccharide Market

  • 6.1. Market Size & Forecast, 2019-2030
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By End Use Application
    • 6.2.3. By Form
    • 6.2.4. By Country
      • 6.2.4.1. United States
      • 6.2.4.1.1. By Product Type
      • 6.2.4.1.2. By End Use Application
      • 6.2.4.1.3. By Form
      • 6.2.4.2. Canada
      • 6.2.4.2.1. By Product Type
      • 6.2.4.2.2. By End Use Application
      • 6.2.4.2.3. By Form

7. Europe Human Milk Oligosaccharide Market

  • 7.1. Market Size & Forecast, 2019-2030
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By End Use Application
    • 7.2.3. By Form
    • 7.2.4. By Country
      • 7.2.4.1. Germany
      • 7.2.4.1.1. By Product Type
      • 7.2.4.1.2. By End Use Application
      • 7.2.4.1.3. By Form
      • 7.2.4.2. United Kingdom
      • 7.2.4.2.1. By Product Type
      • 7.2.4.2.2. By End Use Application
      • 7.2.4.2.3. By Form
      • 7.2.4.3. Italy
      • 7.2.4.3.1. By Product Type
      • 7.2.4.3.2. By End Use Application
      • 7.2.4.3.3. By Form
      • 7.2.4.4. France
      • 7.2.4.4.1. By Product Type
      • 7.2.4.4.2. By End Use Application
      • 7.2.4.4.3. By Form
      • 7.2.4.5. Spain
      • 7.2.4.5.1. By Product Type
      • 7.2.4.5.2. By End Use Application
      • 7.2.4.5.3. By Form
      • 7.2.4.6. Belgium
      • 7.2.4.6.1. By Product Type
      • 7.2.4.6.2. By End Use Application
      • 7.2.4.6.3. By Form
      • 7.2.4.7. Russia
      • 7.2.4.7.1. By Product Type
      • 7.2.4.7.2. By End Use Application
      • 7.2.4.7.3. By Form
      • 7.2.4.8. The Netherlands
      • 7.2.4.8.1. By Product Type
      • 7.2.4.8.2. By End Use Application
      • 7.2.4.8.3. By Form
      • 7.2.4.9. Rest of Europe
      • 7.2.4.9.1. By Product Type
      • 7.2.4.9.2. By End Use Application
      • 7.2.4.9.3. By Form

8. Asia Pacific Human Milk Oligosaccharide Market

  • 8.1. Market Size & Forecast, 2019-2030
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By End Use Application
    • 8.2.3. By Form
    • 8.2.4. By Country
      • 8.2.4.1. China
      • 8.2.4.1.1. By Product Type
      • 8.2.4.1.2. By End Use Application
      • 8.2.4.1.3. By Form
      • 8.2.4.2. India
      • 8.2.4.2.1. By Product Type
      • 8.2.4.2.2. By End Use Application
      • 8.2.4.2.3. By Form
      • 8.2.4.3. Japan
      • 8.2.4.3.1. By Product Type
      • 8.2.4.3.2. By End Use Application
      • 8.2.4.3.3. By Form
      • 8.2.4.4. South Korea
      • 8.2.4.4.1. By Product Type
      • 8.2.4.4.2. By End Use Application
      • 8.2.4.4.3. By Form
      • 8.2.4.5. Australia & New Zealand
      • 8.2.4.5.1. By Product Type
      • 8.2.4.5.2. By End Use Application
      • 8.2.4.5.3. By Form
      • 8.2.4.6. Indonesia
      • 8.2.4.6.1. By Product Type
      • 8.2.4.6.2. By End Use Application
      • 8.2.4.6.3. By Form
      • 8.2.4.7. Malaysia
      • 8.2.4.7.1. By Product Type
      • 8.2.4.7.2. By End Use Application
      • 8.2.4.7.3. By Form
      • 8.2.4.8. Singapore
      • 8.2.4.8.1. By Product Type
      • 8.2.4.8.2. By End Use Application
      • 8.2.4.8.3. By Form
      • 8.2.4.9. Vietnam
      • 8.2.4.9.1. By Product Type
      • 8.2.4.9.2. By End Use Application
      • 8.2.4.9.3. By Form
      • 8.2.4.10. Rest of APAC
      • 8.2.4.10.1. By Product Type
      • 8.2.4.10.2. By End Use Application
      • 8.2.4.10.3. By Form

9. Latin America Human Milk Oligosaccharide Market

  • 9.1. Market Size & Forecast, 2019-2030
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By End Use Application
    • 9.2.3. By Form
    • 9.2.4. By Country
      • 9.2.4.1. Brazil
      • 9.2.4.1.1. By Product Type
      • 9.2.4.1.2. By End Use Application
      • 9.2.4.1.3. By Form
      • 9.2.4.2. Mexico
      • 9.2.4.2.1. By Product Type
      • 9.2.4.2.2. By End Use Application
      • 9.2.4.2.3. By Form
      • 9.2.4.3. Argentina
      • 9.2.4.3.1. By Product Type
      • 9.2.4.3.2. By End Use Application
      • 9.2.4.3.3. By Form
      • 9.2.4.4. Peru
      • 9.2.4.4.1. By Product Type
      • 9.2.4.4.2. By End Use Application
      • 9.2.4.4.3. By Form
      • 9.2.4.5. Rest of LATAM
      • 9.2.4.5.1. By Product Type
      • 9.2.4.5.2. By End Use Application
      • 9.2.4.5.3. By Form

10. Middle East & Africa Human Milk Oligosaccharide Market

  • 10.1. Market Size & Forecast, 2019-2030
    • 10.1.1. By Value (USD Million)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By End Use Application
    • 10.2.3. By Form
    • 10.2.4. By Country
      • 10.2.4.1. Saudi Arabia
      • 10.2.4.1.1. By Product Type
      • 10.2.4.1.2. By End Use Application
      • 10.2.4.1.3. By Form
      • 10.2.4.2. UAE
      • 10.2.4.2.1. By Product Type
      • 10.2.4.2.2. By End Use Application
      • 10.2.4.2.3. By Form
      • 10.2.4.3. Qatar
      • 10.2.4.3.1. By Product Type
      • 10.2.4.3.2. By End Use Application
      • 10.2.4.3.3. By Form
      • 10.2.4.4. Kuwait
      • 10.2.4.4.1. By Product Type
      • 10.2.4.4.2. By End Use Application
      • 10.2.4.4.3. By Form
      • 10.2.4.5. South Africa
      • 10.2.4.5.1. By Product Type
      • 10.2.4.5.2. By End Use Application
      • 10.2.4.5.3. By Form
      • 10.2.4.6. Nigeria
      • 10.2.4.6.1. By Product Type
      • 10.2.4.6.2. By End Use Application
      • 10.2.4.6.3. By Form
      • 10.2.4.7. Algeria
      • 10.2.4.7.1. By Product Type
      • 10.2.4.7.2. By End Use Application
      • 10.2.4.7.3. By Form
      • 10.2.4.8. Rest of MEA
      • 10.2.4.8.1. By Product Type
      • 10.2.4.8.2. By End Use Application
      • 10.2.4.8.3. By Form

11. Competitive Landscape

  • 11.1. List of Key Players and Their Offerings
  • 11.2. Global Human Milk Oligosaccharide Market Share Analysis, 2023
  • 11.3. Competitive Benchmarking, By Operating Parameters
  • 11.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

12. Impact of Escalating Geopolitical Tensions on Global Human Milk Oligosaccharide Market

13. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 13.1. BASF SE
  • 13.2. Abbott Laboratories
  • 13.3. Chr. Hansen Holding A/S
  • 13.4. International Flavors & Fragrances Inc. (DuPont)
  • 13.5. Koninklijke DSM N.V.
  • 13.6. Merck & Co. Inc.
  • 13.7. Royal FrieslandCampina N.V.
  • 13.8. ZuChem Inc.
  • 13.9. Inbiose NV
  • 13.10. Glycosyn LLC
  • 13.11. Kirin Holdings Company (Kyowa Hakko Bio)
  • 13.12. Jennewein Biotechnologie GmbH
  • 13.13. Nestle S.A.
  • 13.14. InnoBio Ltd.
  • 13.15. Elicityl SA
  • 13.16. Other Prominent Players

14. Key Strategic Recommendations

15. Research Methodology

  • 15.1. Qualitative Research
    • 15.1.1. Primary & Secondary Research
  • 15.2. Quantitative Research
  • 15.3. Market Breakdown & Data Triangulation
    • 15.3.1. Secondary Research
    • 15.3.2. Primary Research
  • 15.4. Breakdown of Primary Research Respondents, By Region
  • 15.5. Assumptions & Limitations

*Financial information of case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable